EMEA-001748-PIP03-19 - paediatric investigation plan
arimoclomol citrate
PIPHuman
Orphazyme A/S
Email: contact@orphazyme.com
Tel. +45 39178272
P/0012/2021 : EMA decision of 28 January 2021 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for arimoclomol (citrate) (EMEA-001748-PIP03-19)